The US Food and Drug Administration (FDA) has approved Medtronic’s Altaviva device, intended for the treatment of urge urinary incontinence. This implantable tibial neuromodulation (ITNM) device ...
Astellas Pharma (($ALPMF)) announced an update on their ongoing clinical study. Study Overview: Astellas Pharma, in collaboration with Iota ...
The Universitat Jaume I in Castelló and the Virgen de los Lirios Hospital of the Alcoy Health Department have signed an agreement to develop an industrial doctorate project that will evaluate the ease ...
EDMOND, Okla. – May 13, 2025 -- Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops innovative solutions for women's pelvic health, today announced the peer-reviewed publication of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results